Clinical trial · Observational
Efficacy of Kangliuwan for Recurrent Grade IV Glioma
Efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma: A Prospective Exploratory Clinical Study
NCT03949192CI-TRIAL-00044956unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioma of Brain | — | UNRESOLVED | — |
| Recurrence | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Changes in tumor volume
- timeFrame
- 3 months
- description
- the volume of tumor decreased after taking Kangliuwan
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. The patient signed "informed consent" voluntarily; 2. The age of patient is between 18 and 80 years; 3. KPS score ≥40 ; The patient has normal liver and kidney function Normal heart function Better follow-up and compliance; Exclusion Criteria: 1. The patient did not sign "informed consent" or signed unvoluntarily. 2. Non-glioma patients 3. Active infection 4. Human immunodeficiency virus (HIV) positive 5. Hepatitis C or hepatitis B infective 6. Pregnancy or breast-feeding women 7. Patients did not agree to use effective contraception during treatment and the following 3 months. 8. Patients also participated in other clinical studies. 9. The subjects researchers believe are not suitable for participation or completion of the study.
References
Publications (0)
Data not yet available
No reference posted for this study.